Table 1D. List of urinary and serological proteomic biomarkers discovered in prostate cancer in a South African cohort.
| Potential PCa Proteomic biomarkers | Method used | Biospecimen used | Prevalidated | Ethnic trend |
|---|---|---|---|---|
| MAGEA11 | CAA | Blood | N | N |
| MAGEB1 | CAA | Blood | N | N |
| MAGEB5 | CAA | Blood | N | N |
| MAGEB6 | CAA | Blood | N | N |
| MAPK3 | CAA | Blood | N | Y |
| NY-ESO-1 | CAA | Blood | N | N |
| OIP5 | CAA | Blood | N | Y |
| p53 | CAA | Blood | N | N |
| p53 C141Y | CAA | Blood | N | N |
| p53 K328R | CAA | Blood | N | N |
| p53 L344P | CAA | Blood | N | N |
| p53 Q136X | CAA | Blood | N | N |
| p53 S15A | CAA | Blood | N | Y |
| p53 S392A | CAA | Blood | N | N |
| p53 S46A | CAA | Blood | N | N |
| p53 T18A | CAA | Blood | N | Y |
| PBK | CAA | Blood | N | Y |
| PRKCZ | CAA | Blood | N | N |
| RAF | CAA | Blood | N | N |
| ROPN1A | CAA | Blood | N | Y |
| SPANXA1 | CAA | Blood | N | N |
| SSX2A | CAA | Blood | N | N |
| TKTL1 (Isoform a) | CAA | Blood | N | N |
| ZNF165 | CAA | Blood | N | N |
| CAA= Cancer antigen array; MS= Mass spectrometry; Y=Yes; N=No | ||||